{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:18:35Z","timestamp":1787912315963,"version":"build-2784847793"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00203-026-05006-1","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:19:23Z","timestamp":1782105563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Review: natural compounds as PCSK9 inhibitors for antiviral therapy"],"prefix":"10.1007","volume":"208","author":[{"given":"Radhwan Abdul","family":"Kareem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder Naji","family":"Sameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab H.","family":"Athab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Adil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Qutaiba B.","family":"Allela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"5006_CR1","doi-asserted-by":"publisher","first-page":"40395","DOI":"10.1038\/s41598-025-24155-9","volume":"15","author":"BA Abou-Taleb","year":"2025","unstructured":"Abou-Taleb BA, Elbanan AM, Hammoda HM, Abdelwahab IA, Mohyeldin MM, Ghallab DS (2025) Comparison of Peganum harmala L. leaves extract nanoformulations against herpes simplex virus type 1 guided by network pharmacology analysis. Sci Rep 15:40395","journal-title":"Sci Rep"},{"key":"5006_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.10.034","volume":"74","author":"G Acerbi","year":"2021","unstructured":"Acerbi G et al (2021) Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B. J Hepatol 74:783\u2013793","journal-title":"J Hepatol"},{"key":"5006_CR3","doi-asserted-by":"publisher","unstructured":"Adorni MP, Zimetti F (2020) Naturally Occurring PCSK9 Inhibitors. 12. https:\/\/doi.org\/10.3390\/nu12051440","DOI":"10.3390\/nu12051440"},{"key":"5006_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/nu12051440","volume":"12","author":"MP Adorni","year":"2020","unstructured":"Adorni MP, Zimetti F, Lupo MG, Ruscica M, Ferri N (2020) Naturally occurring PCSK9 inhibitors. Nutrients 12:1440","journal-title":"Nutrients"},{"key":"5006_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.drudis.2022.01.014","volume":"27","author":"S Ahamad","year":"2022","unstructured":"Ahamad S, Mathew S, Khan WA, Mohanan K (2022) Development of small-molecule PCSK9 inhibitors for the treatment of hypercholesterolemia. Drug Discovery Today 27:1332\u20131349","journal-title":"Drug Discovery Today"},{"key":"5006_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/v18010125","volume":"18","author":"A Alanazi","year":"2026","unstructured":"Alanazi A, Ibrahim MN, El Azab EF, Elithy MA (2026) Host Cell Virus Interactions: Molecular Mechanisms, Immune Modulation, Viral Pathogenesis, and Emerging Therapeutic Targets. Viruses 18:125","journal-title":"Viruses"},{"key":"5006_CR7","doi-asserted-by":"publisher","unstructured":"Alannan M, Seidah NG, Merched AJ (2022) PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity. Cells 11. https:\/\/doi.org\/10.3390\/cells11244132","DOI":"10.3390\/cells11244132"},{"key":"5006_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40203-025-00515-1","volume":"14","author":"F Ali","year":"2026","unstructured":"Ali F et al (2026) Mechanistic insights into the synergistic pharmacology of quercetin\u2013kaempferol against SARS-CoV-2 infection. Silico Pharmacol 14:18","journal-title":"Silico Pharmacol"},{"key":"5006_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s13369-025-10420-6","author":"A Alisaac","year":"2025","unstructured":"Alisaac A (2025) Curcumin-Mediated Downregulation of Gene Expression Inhibits Enterococcus faecalis Biofilm Formation. Arab J Sci Eng. https:\/\/doi.org\/10.1007\/s13369-025-10420-6","journal-title":"Arab J Sci Eng"},{"key":"5006_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.36233\/0507-4088-314","volume":"70","author":"EV Anufrieva","year":"2025","unstructured":"Anufrieva EV, Ostankova YV, Davydenko VS, Schemelev AN, Totolian AA (2025) Identification of human genes potentially involved in the pathogenesis of viral hepatitis C based on multi-network bioinformatics analysis. Probl Virol 70:267\u2013281. https:\/\/doi.org\/10.36233\/0507-4088-314","journal-title":"Probl Virol"},{"key":"5006_CR11","doi-asserted-by":"crossref","unstructured":"Aryal M (2026) Health Benefits and Therapeutic Potential of Quercetin. Journal of Food Biochemistry 2026:8094502","DOI":"10.1155\/jfbc\/8094502"},{"key":"5006_CR12","doi-asserted-by":"crossref","unstructured":"Assefi M et al (2023) Potential use of the cholesterol transfer inhibitor U18666A as an antiviral drug for research on various viral infections. Microbial pathogenesis:106096","DOI":"10.1016\/j.micpath.2023.106096"},{"key":"5006_CR13","first-page":"1099","volume":"21","author":"S Ataei","year":"2022","unstructured":"Ataei S, Kesharwani P, Sahebkar A (2022a) Berberine: Ins and outs of a nature-made PCSK9 inhibitor. EXCLI J 21:1099","journal-title":"EXCLI J"},{"key":"5006_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.17179\/excli2022-5234","volume":"21","author":"S Ataei","year":"2022","unstructured":"Ataei S, Kesharwani P, Sahebkar A (2022b) Berberine: Ins and outs of a nature-made PCSK9 inhibitor. Excli j 21:1099\u20131110. https:\/\/doi.org\/10.17179\/excli2022-5234","journal-title":"Excli j"},{"key":"5006_CR15","first-page":"161","volume":"91","author":"M Baglivo","year":"2020","unstructured":"Baglivo M et al (2020) Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? Acta Bio Medica: Atenei Parmensis 91:161","journal-title":"Acta Bio Medica: Atenei Parmensis"},{"key":"5006_CR16","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.4103\/pr.pr_30_17","volume":"9","author":"S Baikerikar","year":"2017","unstructured":"Baikerikar S (2017) Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach. Pharmacognosy Res 9:S15\u2013s22. https:\/\/doi.org\/10.4103\/pr.pr_30_17","journal-title":"Pharmacognosy Res"},{"key":"5006_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.virol.2017.07.024","volume":"510","author":"S Bajimaya","year":"2017","unstructured":"Bajimaya S, Frankl T, Hayashi T, Takimoto T (2017a) Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology 510:234\u2013241","journal-title":"Virology"},{"key":"5006_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.virol.2016.11.011","volume":"501","author":"S Bajimaya","year":"2017","unstructured":"Bajimaya S, Hayashi T, Frankl T, Bryk P, Ward B, Takimoto T (2017b) Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses. Virology 501:127\u2013135. https:\/\/doi.org\/10.1016\/j.virol.2016.11.011","journal-title":"Virology"},{"key":"5006_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2018.12.002","volume":"162","author":"A Balasubramanian","year":"2019","unstructured":"Balasubramanian A et al (2019) Inhibition of dengue virus by curcuminoids. Antiviral Res 162:71\u201378","journal-title":"Antiviral Res"},{"key":"5006_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41392-023-01690-3","volume":"9","author":"X Bao","year":"2024","unstructured":"Bao X et al (2024) Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside. Signal Transduct Target Therapy 9:13. https:\/\/doi.org\/10.1038\/s41392-023-01690-3","journal-title":"Signal Transduct Target Therapy"},{"key":"5006_CR21","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.3390\/ijms22115880","volume":"22","author":"C Barale","year":"2021","unstructured":"Barale C, Melchionda E, Morotti A, Russo I (2021) PCSK9 biology and its role in atherothrombosis. Int J Mol Sci 22:5880","journal-title":"Int J Mol Sci"},{"key":"5006_CR22","doi-asserted-by":"crossref","unstructured":"Basak A, O\u2019Reilly P, Ozed-Williams B, Basak S (2018) Small molecule phytocompounds as promoters of LDL-receptor and PCSK9 inhibition: Potential role as non-statin based cardio-protective agents. In: Brahmachari G (ed) Cardioprotective Natural Products: Promises And Hopes. World Scientific, pp 277\u2013318","DOI":"10.1142\/9789813231160_0008"},{"key":"5006_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/2666796702666210329141042","volume":"2","author":"A Basak","year":"2021","unstructured":"Basak A, Vaijanathappa J, Basak S (2021) Lipid Lowering Natural Products Targeting hPCSK9 May Prevent the Severity of COVID-19 Infection. Coronaviruses 2:10\u201323","journal-title":"Coronaviruses"},{"key":"5006_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/en.2010-1157","volume":"152","author":"S Bauer","year":"2011","unstructured":"Bauer S et al (2011) Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 152:26\u201335","journal-title":"Endocrinology"},{"key":"5006_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/ph14040381","volume":"14","author":"T Behl","year":"2021","unstructured":"Behl T et al (2021) Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview. Pharmaceuticals 14:381","journal-title":"Pharmaceuticals"},{"key":"5006_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-444-63281-4.00007-0","volume":"42","author":"A Bekhit","year":"2014","unstructured":"Bekhit A, Bekhit A (2014) Natural antiviral compounds. Stud Nat Prod Chem 42:195\u2013228","journal-title":"Stud Nat Prod Chem"},{"key":"5006_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2022.06.447","volume":"355","author":"L Benchagra","year":"2022","unstructured":"Benchagra L, Alami M, Boulbaroud S, Khalil A, Ramchoun M, Berrougui H (2022) Moroccan pomegranate (sefri variety) polyphenols prevent hyperlipidemia, oxidative stress and enhance cholesterol efflux processes. Atherosclerosis 355:73\u201374","journal-title":"Atherosclerosis"},{"key":"5006_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/biomedicines9020200","volume":"9","author":"NN Besednova","year":"2021","unstructured":"Besednova NN et al (2021) Antiviral effects of polyphenols from marine algae. Biomedicines 9:200","journal-title":"Biomedicines"},{"key":"5006_CR29","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1038\/s41598-020-61700-0","volume":"10","author":"R Borenstein","year":"2020","unstructured":"Borenstein R et al (2020) Ginkgolic acid inhibits fusion of enveloped viruses. Sci Rep 10:4746","journal-title":"Sci Rep"},{"key":"5006_CR30","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1002\/ptr.7122","volume":"35","author":"JCM Brito","year":"2021","unstructured":"Brito JCM, Lima WG, Cordeiro LPB, da Cruz Nizer WS (2021) Effectiveness of supplementation with quercetin-type flavonols for treatment of viral lower respiratory tract infections: Systematic review and meta\u2010analysis of preclinical studies. Phytother Res 35:4930\u20134942","journal-title":"Phytother Res"},{"key":"5006_CR31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/1750-3841.13647","volume":"82","author":"Y Cai","year":"2017","unstructured":"Cai Y et al (2017) Curcumin protects against intestinal origin endotoxemia in rat liver cirrhosis by targeting PCSK9. J Food Sci 82:772\u2013780","journal-title":"J Food Sci"},{"key":"5006_CR32","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.1128\/JVI.01473-15","volume":"89","author":"N Calland","year":"2015","unstructured":"Calland N et al (2015) Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. J Virol 89:10053\u201310063","journal-title":"J Virol"},{"key":"5006_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3390\/pharmaceutics17091229","volume":"17","author":"MF Calmon","year":"2025","unstructured":"Calmon MF et al (2025) Antiviral Activity of Liposomes Containing Natural Compounds Against CHIKV. Pharmaceutics 17:1229","journal-title":"Pharmaceutics"},{"key":"5006_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2008.02.004","volume":"201","author":"J Cameron","year":"2008","unstructured":"Cameron J, Ranheim T, Kulseth MA, Leren TP, Berge KE (2008) Berberine decreases PCSK9 expression in HepG2 cells. Atherosclerosis 201:266\u2013273","journal-title":"Atherosclerosis"},{"key":"5006_CR35","unstructured":"Catapano AL et al (2026) Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial. JACC"},{"key":"5006_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4330\/wjc.v9.i2.76","volume":"9","author":"R Chaudhary","year":"2017","unstructured":"Chaudhary R, Garg J, Shah N, Sumner A (2017) PCSK9 inhibitors: A new era of lipid lowering therapy. World J Cardiol 9:76\u201391. https:\/\/doi.org\/10.4330\/wjc.v9.i2.76","journal-title":"World J Cardiol"},{"key":"5006_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.foodchem.2009.09.011","volume":"119","author":"D-Y Chen","year":"2010","unstructured":"Chen D-Y et al (2010) Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem 119:1346\u20131351","journal-title":"Food Chem"},{"key":"5006_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3892\/ijmm.2012.1096","volume":"30","author":"M-H Chen","year":"2012","unstructured":"Chen M-H et al (2012) Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Int J Mol Med 30:1021\u20131028","journal-title":"Int J Mol Med"},{"key":"5006_CR40","doi-asserted-by":"publisher","first-page":"e62482","DOI":"10.1371\/journal.pone.0062482","volume":"8","author":"T-Y Chen","year":"2013","unstructured":"Chen T-Y et al (2013) Inhibition of enveloped viruses infectivity by curcumin. PLoS ONE 8:e62482","journal-title":"PLoS ONE"},{"key":"5006_CR37","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.2174\/1568026619666190809094203","volume":"19","author":"B Chen","year":"2019","unstructured":"Chen B, Shi X, Cui Y, Hou A, Zhao P (2019) A review of PCSK9 inhibitors and their effects on cardiovascular diseases. Curr Top Med Chem 19:1790\u20131817","journal-title":"Curr Top Med Chem"},{"key":"5006_CR41","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/foods10102277","volume":"10","author":"K Chojnacka","year":"2021","unstructured":"Chojnacka K, Skrzypczak D, Izydorczyk G, Mikula K, Szopa D, Witek-Krowiak A (2021) Antiviral properties of polyphenols from plants. Foods 10:2277","journal-title":"Foods"},{"key":"5006_CR42","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jep.2011.06.041","volume":"137","author":"SC Chong","year":"2011","unstructured":"Chong SC, Dollah MA, Chong PP, Maha A (2011) Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro. J Ethnopharmacol 137:817\u2013827","journal-title":"J Ethnopharmacol"},{"key":"5006_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/17425247.2025.2609682","volume":"23","author":"Z Choonia","year":"2026","unstructured":"Choonia Z, Patil K, Fernandes T, Narayanan S, Sawarkar S, Omri A (2026) Revolutionizing antiviral therapy: harnessing nanotechnology to unlock the power of phytoconstituents. Expert Opin Drug Deliv 23:661\u2013679","journal-title":"Expert Opin Drug Deliv"},{"key":"5006_CR44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/nutrit\/nux047","volume":"75","author":"AF Cicero","year":"2017","unstructured":"Cicero AF et al (2017) Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 75:731\u2013767","journal-title":"Nutr Rev"},{"key":"5006_CR45","first-page":"100127","volume":"13","author":"AF Cicero","year":"2022","unstructured":"Cicero AF, Fogacci F, Zambon A, Toth PP, Borghi C (2022a) Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies. Am Heart J Plus: Cardiol Res Pract 13:100127","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"key":"5006_CR46","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.ahjo.2022.100127","volume":"13","author":"AFG Cicero","year":"2022","unstructured":"Cicero AFG, Fogacci F, Zambon A, Toth PP, Borghi C (2022b) Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies. Am Heart J Plus 13:100127. https:\/\/doi.org\/10.1016\/j.ahjo.2022.100127","journal-title":"Am Heart J Plus"},{"key":"5006_CR47","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gutjnl-2012-304299","volume":"63","author":"CC Colpitts","year":"2014","unstructured":"Colpitts CC et al (2014) Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut 63:1137\u20131149","journal-title":"Gut"},{"key":"5006_CR48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/nu18050722","volume":"18","author":"G Corsetti","year":"2026","unstructured":"Corsetti G, Pasini E (2026) Beyond Cholesterol Lowering: Clinical Caution, Personalization, and Nutritional Integration in Statin Therapy. Nutrients 18:722","journal-title":"Nutrients"},{"key":"5006_CR49","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1074\/jbc.M508582200","volume":"281","author":"P Costet","year":"2006","unstructured":"Costet P et al (2006) Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c. J Biol Chem 281:6211\u20136218","journal-title":"J Biol Chem"},{"key":"5006_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02362-4","volume":"18","author":"C-J Cui","year":"2020","unstructured":"Cui C-J et al (2020) Beneficial impact of epigallocatechingallate on LDL-C through PCSK9\/LDLR pathway by blocking HNF1\u03b1 and activating FoxO3a. J translational Med 18:1\u201313","journal-title":"J translational Med"},{"key":"5006_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0973-7847.194044","volume":"10","author":"AVA David","year":"2016","unstructured":"David AVA, Arulmoli R, Parasuraman S (2016) Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn Rev 10:84","journal-title":"Pharmacogn Rev"},{"key":"5006_CR52","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ptr.6887","volume":"35","author":"G Derosa","year":"2021","unstructured":"Derosa G, Maffioli P, D\u2019Angelo A, Di Pierro F (2021) A role for quercetin in coronavirus disease 2019 (COVID-19). Phytother Res 35:1230\u20131236","journal-title":"Phytother Res"},{"key":"5006_CR53","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ptr.7309","volume":"36","author":"A Di Petrillo","year":"2022","unstructured":"Di Petrillo A, Orr\u00f9 G, Fais A, Fantini MC (2022) Quercetin and its derivates as antiviral potentials: A comprehensive review. Phytother Res 36:266\u2013278. https:\/\/doi.org\/10.1002\/ptr.7309","journal-title":"Phytother Res"},{"key":"5006_CR54","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1074\/jbc.M114.597229","volume":"290","author":"B Dong","year":"2015","unstructured":"Dong B, Li H, Singh AB, Cao A, Liu J (2015) Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1\u03b1 protein expression through the ubiquitin-proteasome degradation pathway. J Biol Chem 290:4047\u20134058","journal-title":"J Biol Chem"},{"key":"5006_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-025-02539-7","volume":"11","author":"S Du","year":"2026","unstructured":"Du S et al (2026) Antiviral drug discovery and development: challenges and future directions. Signal Transduct Target Therapy 11:69","journal-title":"Signal Transduct Target Therapy"},{"key":"5006_CR56","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","volume":"24","author":"G Dubuc","year":"2004","unstructured":"Dubuc G et al (2004) Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 24:1454\u20131459","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5006_CR57","doi-asserted-by":"publisher","first-page":"101555","DOI":"10.1016\/j.coviro.2026.101555","volume":"76","author":"N Ebersberger","year":"2026","unstructured":"Ebersberger N, Vieyres G, Krey T (2026) Lipoprotein receptors in hepatitis C virus entry\u2014a structural view. Curr Opin Virol 76:101555","journal-title":"Curr Opin Virol"},{"key":"5006_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/v15020360","volume":"15","author":"R Essalmani","year":"2023","unstructured":"Essalmani R et al (2023) SKI-1\/S1P facilitates SARS-CoV-2 spike induced cell-to-cell fusion via activation of SREBP-2 and metalloproteases, whereas PCSK9 enhances the degradation of ACE2. Viruses 15:360","journal-title":"Viruses"},{"key":"5006_CR59","doi-asserted-by":"crossref","unstructured":"Evangelista J, Schultz C, Tafesse FG (2026) Emerging roles of lipids in the flavivirus life cycle. Trends in microbiology","DOI":"10.20944\/preprints202512.1513.v1"},{"key":"5006_CR60","doi-asserted-by":"publisher","first-page":"104994","DOI":"10.1016\/j.bioorg.2021.104994","volume":"113","author":"T-Y Fan","year":"2021","unstructured":"Fan T-Y et al (2021) Structure\u2013activity relationship and biological evaluation of berberine derivatives as PCSK9 down-regulating agents. Bioorg Chem 113:104994","journal-title":"Bioorg Chem"},{"key":"5006_CR61","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamacardio.2025.0244","volume":"10","author":"AC Fanaroff","year":"2025","unstructured":"Fanaroff AC et al (2025) Encouraging pharmacist referrals for evidence-based statin initiation: two cluster randomized clinical trials. JAMA Cardiol 10:473\u2013481","journal-title":"JAMA Cardiol"},{"key":"5006_CR62","doi-asserted-by":"crossref","unstructured":"Fang H et al (2025) PCSK9 potentiates innate immune response to RNA viruses by preventing AIP4-mediated polyubiquitination and degradation of VISA\/MAVS. Proceedings of the National Academy of Sciences 122:e2412206122","DOI":"10.1073\/pnas.2412206122"},{"key":"5006_CR63","doi-asserted-by":"publisher","unstructured":"Fasolato S et al (2020) PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma. J Clin Med 9. https:\/\/doi.org\/10.3390\/jcm9103134","DOI":"10.3390\/jcm9103134"},{"key":"5006_CR64","doi-asserted-by":"crossref","unstructured":"Fassi EMA, Albani M, D\u2019Adduzio L, Milano EG, Lammi C, Grazioso G (2026) PCSK9 inhibitors: an updated patent review 2024\u20132025. Expert Opinion on Therapeutic Patents","DOI":"10.1080\/13543776.2026.2674748"},{"key":"5006_CR65","doi-asserted-by":"publisher","unstructured":"Feng H et al (2026) Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8\u2009+\u2009T cell immunity via rewiring MHC-I antigen presentation. Cell Rep Med 7(4):102724 https:\/\/doi.org\/10.1016\/j.xcrm.2026.102724","DOI":"10.1016\/j.xcrm.2026.102724"},{"key":"5006_CR66","doi-asserted-by":"publisher","first-page":"105724","DOI":"10.1016\/j.jff.2023.105724","volume":"108","author":"I Ferrarese","year":"2023","unstructured":"Ferrarese I et al (2023) Bergamot (Citrus bergamia) peel extract as new hypocholesterolemic agent modulating PCSK9 expression. J Funct Foods 108:105724","journal-title":"J Funct Foods"},{"key":"5006_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-020-00844-w","volume":"22","author":"N Ferri","year":"2020","unstructured":"Ferri N, Corsini A (2020) Clinical pharmacology of statins: an update. Curr Atheroscler Rep 22:1\u20139","journal-title":"Curr Atheroscler Rep"},{"key":"5006_CR68","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.mib.2011.07.012","volume":"14","author":"W Fischl","year":"2011","unstructured":"Fischl W, Bartenschlager R (2011) Exploitation of cellular pathways by Dengue virus. Curr Opin Microbiol 14:470\u2013475","journal-title":"Curr Opin Microbiol"},{"key":"5006_CR69","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1089\/jmf.2019.0168","volume":"23","author":"E Formisano","year":"2020","unstructured":"Formisano E et al (2020) Efficacy of nutraceutical combination of monacolin K, berberine, and silymarin on lipid profile and PCSK9 plasma level in a cohort of hypercholesterolemic patients. J Med Food 23:658\u2013666","journal-title":"J Med Food"},{"key":"5006_CR70","doi-asserted-by":"publisher","unstructured":"Forouzanfar F, Meshkat Z (2025) A Review of the Antiviral Activity of Berberine. Curr Drug Discov Technol 22. https:\/\/doi.org\/10.2174\/0115701638360834250113111936","DOI":"10.2174\/0115701638360834250113111936"},{"key":"5006_CR71","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1172\/JCI137536","volume":"130","author":"ES Gan","year":"2020","unstructured":"Gan ES et al (2020a) Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes. J Clin Investig 130:5223\u20135234","journal-title":"J Clin Investig"},{"key":"5006_CR72","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1172\/jci137536","volume":"130","author":"ES Gan","year":"2020","unstructured":"Gan ES et al (2020b) Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes. J Clin Invest 130:5223\u20135234. https:\/\/doi.org\/10.1172\/jci137536","journal-title":"J Clin Invest"},{"key":"5006_CR73","doi-asserted-by":"publisher","first-page":"109152","DOI":"10.1016\/j.vetmic.2021.109152","volume":"259","author":"Y Gao","year":"2021","unstructured":"Gao Y et al (2021) Curcumin inhibits classical swine fever virus replication by interfering with lipid metabolism. Vet Microbiol 259:109152","journal-title":"Vet Microbiol"},{"key":"5006_CR74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2019.02.015","volume":"284","author":"B Gencer","year":"2019","unstructured":"Gencer B et al (2019) Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients na\u00efve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort. Atherosclerosis 284:253\u2013259","journal-title":"Atherosclerosis"},{"key":"5006_CR75","first-page":"1529","volume":"7","author":"DA Ghareeb","year":"2013","unstructured":"Ghareeb DA, Abd El-Wahab AE, Sarhan EE, Abu-Serie MM, El Demellawy MA (2013) Biological assessment of Berberis vulgaris and its active constituent, berberine: Antibacterial, antifungal and anti-hepatitis C virus (HCV) effect. J Med Plants Res 7:1529\u20131536","journal-title":"J Med Plants Res"},{"key":"5006_CR76","first-page":"19","volume":"85","author":"GW Go","year":"2012","unstructured":"Go GW, Mani A (2012) Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J Biol Med 85:19\u201328","journal-title":"Yale J Biol Med"},{"key":"5006_CR77","doi-asserted-by":"publisher","unstructured":"Gong Y, Cun W (2019) The Role of ApoE in HCV Infection and Comorbidity. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20082037","DOI":"10.3390\/ijms20082037"},{"key":"5006_CR78","unstructured":"Gonzalez PO et al (2021) Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis. bioRxiv"},{"key":"5006_CR79","doi-asserted-by":"publisher","first-page":"2200139","DOI":"10.1002\/mnfr.202200139","volume":"66","author":"J Grafeneder","year":"2022","unstructured":"Grafeneder J et al (2022) Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK-9 Concentrations in Healthy Subjects in a Double\u2010Blind, Randomized, Active\u2010Controlled, Crossover Trial. Mol Nutr Food Res 66:2200139","journal-title":"Mol Nutr Food Res"},{"key":"5006_CR80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15:195\u2013218","journal-title":"AAPS J"},{"key":"5006_CR81","doi-asserted-by":"publisher","first-page":"111931","DOI":"10.1016\/j.matdes.2023.111931","volume":"229","author":"C-p He","year":"2023","unstructured":"He C-p et al (2023) Construction of nicotinic acid curcumin nanoparticles and its Anti-atherosclerosis effect via PCSK9\/LDL-R, ABCA1\/Caveolin-1\/LXR pathway. Mater Design 229:111931","journal-title":"Mater Design"},{"key":"5006_CR83","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.chom.2010.10.006","volume":"8","author":"NS Heaton","year":"2010","unstructured":"Heaton NS, Randall G (2010) Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8:422\u2013432","journal-title":"Cell Host Microbe"},{"key":"5006_CR82","doi-asserted-by":"crossref","unstructured":"Heaton NS et al (2010) Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proceedings of the National Academy of Sciences 107:17345\u201317350","DOI":"10.1073\/pnas.1010811107"},{"key":"5006_CR84","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1161\/ATVBAHA.120.315708","volume":"41","author":"D Hu","year":"2021","unstructured":"Hu D et al (2021) New insight into metformin-induced cholesterol-lowering effect crosstalk between glucose and cholesterol homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-mediated PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) regulation. Arterioscler Thromb Vasc Biol 41:e208\u2013e223","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5006_CR85","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/vetsci12050447","volume":"12","author":"X Hui","year":"2025","unstructured":"Hui X et al (2025) A review of Cross-Species transmission mechanisms of influenza viruses. Veterinary Sci 12:447","journal-title":"Veterinary Sci"},{"key":"5006_CR86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phymed.2018.09.025","volume":"53","author":"T-C Hung","year":"2019","unstructured":"Hung T-C et al (2019) Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. Phytomedicine 53:62\u201369","journal-title":"Phytomedicine"},{"key":"5006_CR87","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/antibiotics11030322","volume":"11","author":"Y Hussain","year":"2022","unstructured":"Hussain Y et al (2022) Antimicrobial potential of curcumin: therapeutic potential and challenges to clinical applications. Antibiotics 11:322","journal-title":"Antibiotics"},{"key":"5006_CR88","doi-asserted-by":"crossref","unstructured":"Iqbal M, Hasanah N, Arianto AD, Aryati WD, Puteri MU, Saputri FC (2023) Brazilin from Caesalpinia sappan L. as a Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9) Inhibitor: Pharmacophore-Based Virtual Screening, In Silico Molecular Docking, and In Vitro Studies. Advances in Pharmacological and Pharmaceutical Sciences 2023","DOI":"10.1155\/2023\/5932315"},{"key":"5006_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/eurheartj\/ehz566","volume":"41","author":"H-D Jang","year":"2020","unstructured":"Jang H-D et al (2020) Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin\/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin\/kexin type-9. Eur Heart J 41:239\u2013252","journal-title":"Eur Heart J"},{"key":"5006_CR90","doi-asserted-by":"publisher","first-page":"1412236","DOI":"10.3389\/fcell.2024.1412236","volume":"12","author":"AA Jawabri","year":"2024","unstructured":"Jawabri AA et al (2024) Cellular and functional evaluation of LDLR missense variants reported in hypercholesterolemic patients demonstrates their hypomorphic impacts on trafficking and LDL internalization. Front Cell Dev Biol 12:1412236. https:\/\/doi.org\/10.3389\/fcell.2024.1412236","journal-title":"Front Cell Dev Biol"},{"key":"5006_CR91","doi-asserted-by":"publisher","first-page":"109338","DOI":"10.1016\/j.biopha.2019.109338","volume":"118","author":"X Ji","year":"2019","unstructured":"Ji X et al (2019) Bioactive compounds from herbal medicines to manage dyslipidemia. Biomed Pharmacother 118:109338","journal-title":"Biomed Pharmacother"},{"key":"5006_CR92","first-page":"893","volume":"44","author":"Q Jia","year":"2019","unstructured":"Jia Q et al (2019) Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPAR\u03b3, LXR\u03b1 and ABCA1. Int J Mol Med 44:893\u2013902","journal-title":"Int J Mol Med"},{"key":"5006_CR93","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3390\/ph18081150","volume":"18","author":"N Jianu","year":"2025","unstructured":"Jianu N et al (2025) A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II. Pharmaceuticals 18:1150","journal-title":"Pharmaceuticals"},{"key":"5006_CR94","doi-asserted-by":"publisher","first-page":"106167","DOI":"10.1016\/j.antiviral.2025.106167","volume":"238","author":"JA Kelly","year":"2025","unstructured":"Kelly JA et al (2025) Mechanisms of action of repurposed Ebola virus antivirals \u2013 the roles of phospholipidosis and cholesterol homeostasis. Antiviral Res 238:106167. https:\/\/doi.org\/10.1016\/j.antiviral.2025.106167","journal-title":"Antiviral Res"},{"key":"5006_CR95","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","volume":"584","author":"K Kim","year":"2010","unstructured":"Kim K, Kim KH, Kim HY, Cho HK, Sakamoto N, Cheong J (2010) Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett 584:707\u2013712","journal-title":"FEBS Lett"},{"key":"5006_CR96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2613.2003.00344.x","volume":"84","author":"P Kumar","year":"2003","unstructured":"Kumar P, Sharma S, Khanna M, Raj HG (2003) Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. Int J Exp Pathol 84:127\u2013134","journal-title":"Int J Exp Pathol"},{"key":"5006_CR97","doi-asserted-by":"publisher","first-page":"e009996","DOI":"10.1161\/JAHA.118.009996","volume":"7","author":"TM Leucker","year":"2018","unstructured":"Leucker TM et al (2018) Coronary endothelial dysfunction is associated with elevated serum PCSK9 Levels in people with HIV independent of low-density lipoprotein cholesterol. J Am Heart Association 7:e009996","journal-title":"J Am Heart Association"},{"key":"5006_CR99","doi-asserted-by":"publisher","first-page":"28885","DOI":"10.1074\/jbc.M109.052407","volume":"284","author":"H Li","year":"2009","unstructured":"Li H, Dong B, Park SW, Lee H-S, Chen W, Liu J (2009) Hepatocyte nuclear factor 1\u03b1 plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. J Biol Chem 284:28885\u201328895","journal-title":"J Biol Chem"},{"key":"5006_CR103","doi-asserted-by":"crossref","unstructured":"Li Z, Geng Y-N, Jiang J-D, Kong W-J (2014) Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evidence-based complementary and alternative medicine 2014","DOI":"10.1155\/2014\/289264"},{"key":"5006_CR100","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3390\/molecules23092397","volume":"23","author":"L Li","year":"2018","unstructured":"Li L et al (2018a) A new strategy for rapidly screening natural inhibitors targeting the PCSK9\/LDLR interaction in vitro. Molecules 23:2397","journal-title":"Molecules"},{"key":"5006_CR102","first-page":"799","volume":"18","author":"S Li","year":"2018","unstructured":"Li S, Cao H, Shen D, Jia Q, Chen C, Xing SL (2018b) Quercetin protects against ox\u2013LDL\u2013induced injury via regulation of ABCAl, LXR\u2013\u03b1 and PCSK9 in RAW264. 7 macrophages. Mol Med Rep 18:799\u2013806","journal-title":"Mol Med Rep"},{"key":"5006_CR101","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11655-019-2942-9","volume":"26","author":"S-s Li","year":"2020","unstructured":"Li S-s et al (2020) Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-\u03b1 and PCSK9 in ApoE-\/-Mice. Chin J Integr Med 26:114\u2013121","journal-title":"Chin J Integr Med"},{"key":"5006_CR98","doi-asserted-by":"crossref","unstructured":"Li G et al (2021) NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry. Sci China Life Sci 65:341","DOI":"10.1007\/s11427-021-1929-y"},{"key":"5006_CR104","doi-asserted-by":"publisher","first-page":"857092","DOI":"10.3389\/fphar.2022.857092","volume":"13","author":"J Liang","year":"2022","unstructured":"Liang J et al (2022) Di\u2019ao Xinxuekang Capsule improves the anti-atherosclerotic effect of atorvastatin by downregulating the SREBP2\/PCSK9 signalling pathway. Front Pharmacol 13:857092","journal-title":"Front Pharmacol"},{"key":"5006_CR105","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/antiox10081280","volume":"10","author":"Y-K Lin","year":"2021","unstructured":"Lin Y-K et al (2021) Pterostilbene increases LDL metabolism in HL-1 cardiomyocytes by modulating the PCSK9\/HNF1\u03b1\/SREBP2\/LDLR signaling cascade, upregulating epigenetic hsa-miR-335 and hsa-miR-6825, and LDL receptor expression. Antioxidants 10:1280","journal-title":"Antioxidants"},{"key":"5006_CR106","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.3390\/ijms23073897","volume":"23","author":"J-W Liou","year":"2022","unstructured":"Liou J-W, Mani H, Yen J-H (2022) Viral hepatitis, cholesterol metabolism, and cholesterol-lowering natural compounds. Int J Mol Sci 23:3897","journal-title":"Int J Mol Sci"},{"key":"5006_CR107","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/membranes11100784","volume":"11","author":"C-H Liu","year":"2021","unstructured":"Liu C-H, Huang S-J, Yu T-Y (2021) Cholesterol Modulates the Interaction between HIV-1 Viral Protein R and Membrane. Membranes 11:784","journal-title":"Membranes"},{"key":"5006_CR108","doi-asserted-by":"publisher","first-page":"e2356445","DOI":"10.1001\/jamanetworkopen.2023.56445","volume":"7","author":"CT Longenecker","year":"2024","unstructured":"Longenecker CT et al (2024) Nurse-Led Strategy to Improve Blood Pressure and Cholesterol Level Among People With HIV: A Randomized Clinical Trial. JAMA Netw Open 7:e2356445\u2013e2356445","journal-title":"JAMA Netw Open"},{"key":"5006_CR109","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/17435889.2025.2452151","volume":"20","author":"YS Loo","year":"2025","unstructured":"Loo YS et al (2025) Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy. Nanomedicine 20:401\u2013416","journal-title":"Nanomedicine"},{"key":"5006_CR110","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/rai2.12169","volume":"5","author":"A Lopez","year":"2025","unstructured":"Lopez A et al (2025) Effect of statins on psoriasis severity: A meta-analysis of randomized clinical trials. Rheumatol Autoimmun 5:119\u2013129","journal-title":"Rheumatol Autoimmun"},{"key":"5006_CR111","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ptr.5518","volume":"30","author":"NT Lu","year":"2016","unstructured":"Lu NT et al (2016) A phase I dose escalation study demonstrates quercetin safety and explores potential for bioflavonoid antivirals in patients with chronic hepatitis C. Phytother Res 30:160\u2013168","journal-title":"Phytother Res"},{"key":"5006_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00044-024-03321-0","volume":"34","author":"Y Lu","year":"2025","unstructured":"Lu Y, Yin M, Lai Y, Ye X, Chen M, Li Y (2025) Structural modifications of berberine and the lipid-regulating effects of its derivatives. Med Chem Res 34:1\u201318. https:\/\/doi.org\/10.1007\/s00044-024-03321-0","journal-title":"Med Chem Res"},{"key":"5006_CR113","doi-asserted-by":"publisher","first-page":"937474","DOI":"10.3389\/fcvm.2022.937474","volume":"9","author":"P Lv","year":"2022","unstructured":"Lv P et al (2022) PCSK9 inhibitors in a renal transplant patient complicated with hepatitis B: A case report and literature review. Front Cardiovasc Med 9:937474","journal-title":"Front Cardiovasc Med"},{"key":"5006_CR114","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.21037\/atm-20-8106","volume":"9","author":"CY Ma","year":"2021","unstructured":"Ma CY et al (2021) Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE(-\/-) mice by down-regulating PCSK9 via ERK1\/2 pathway. Ann Transl Med 9:1517. https:\/\/doi.org\/10.21037\/atm-20-8106","journal-title":"Ann Transl Med"},{"key":"5006_CR115","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43088-023-00387-4","volume":"12","author":"AR Mahmud","year":"2023","unstructured":"Mahmud AR et al (2023) Natural flavonols: Actions, mechanisms, and potential therapeutic utility for various diseases. Beni-Suef Univ J Basic Appl Sci 12:47","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"5006_CR116","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12291-019-00858-5","volume":"36","author":"ML Majeed","year":"2021","unstructured":"Majeed ML, Ghafil FA, Fatima G, Hadi NR, Mahdi HF (2021) Anti-Atherosclerotic and Anti-Inflammatory Effects of Curcumin on Hypercholesterolemic Male Rabbits. Indian J Clin Biochem 36:74\u201380","journal-title":"Indian J Clin Biochem"},{"key":"5006_CR117","first-page":"28","volume":"41","author":"M Manniello","year":"2016","unstructured":"Manniello M, Pisano M (2016) Alirocumab (Praluent): First in the New Class of PCSK9 Inhibitors. P t 41:28\u201353","journal-title":"P t"},{"key":"5006_CR118","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/molecules26226900","volume":"26","author":"D Mar\u00edn-Palma","year":"2021","unstructured":"Mar\u00edn-Palma D et al (2021) Curcumin inhibits in vitro SARS-CoV-2 infection in Vero E6 cells through multiple antiviral mechanisms. Molecules 26:6900 https:\/\/pubmed.ncbi.nlm.nih.gov\/34833991\/","journal-title":"Molecules"},{"key":"5006_CR119","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jff.2017.12.017","volume":"40","author":"D Mathew","year":"2018","unstructured":"Mathew D, Hsu W-L (2018) Antiviral potential of curcumin. J Funct Foods 40:692\u2013699","journal-title":"J Funct Foods"},{"key":"5006_CR120","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.fob.2014.08.003","volume":"4","author":"M Mbikay","year":"2014","unstructured":"Mbikay M, Sirois F, Simoes S, Mayne J, Chr\u00e9tien M (2014) Quercetin-3-glucoside increases low-density lipoprotein receptor (LDLR) expression, attenuates proprotein convertase subtilisin\/kexin 9 (PCSK9) secretion, and stimulates LDL uptake by Huh7 human hepatocytes in culture. FEBS open bio 4:755\u2013762","journal-title":"FEBS open bio"},{"key":"5006_CR121","doi-asserted-by":"publisher","first-page":"104107","DOI":"10.1016\/j.drudis.2024.104107","volume":"29","author":"SK Mehta","year":"2024","unstructured":"Mehta SK, Pradhan RB (2024) Phytochemicals in antiviral drug development against human respiratory viruses. Drug Discovery Today 29:104107. https:\/\/doi.org\/10.1016\/j.drudis.2024.104107","journal-title":"Drug Discovery Today"},{"key":"5006_CR122","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12964-023-01250-w","volume":"21","author":"X Meng","year":"2023","unstructured":"Meng X et al (2023) The roles of different microRNAs in the regulation of cholesterol in viral hepatitis. Cell Communication Signal 21:231","journal-title":"Cell Communication Signal"},{"key":"5006_CR123","doi-asserted-by":"publisher","first-page":"153286","DOI":"10.1016\/j.phymed.2020.153286","volume":"85","author":"S Mhatre","year":"2021","unstructured":"Mhatre S, Srivastava T, Naik S, Patravale V (2021) Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine 85:153286","journal-title":"Phytomedicine"},{"key":"5006_CR124","doi-asserted-by":"crossref","unstructured":"Miao J, Wang J, Zhou W, Guo J (2026) Small-molecule PCSK9 inhibition enhances BBB amyloid-\u03b2 clearance and suppresses microglial inflammation in Alzheimer\u2019s disease models. Scientific Reports","DOI":"10.1038\/s41598-026-46671-y"},{"key":"5006_CR125","doi-asserted-by":"crossref","unstructured":"Miltonprabu S (2019) Quercetin: a flavonol with versatile therapeutic applications and its interactions with other drugs. In: Seyed Mohammad N, Ana Sanches S (eds) Nonvitamin and nonmineral nutritional supplements. Elsevier, pp 75\u201383 https:\/\/www.sciencedirect.com\/book\/edited-volume\/9780128124918\/nonvitamin-and-nonmineral-nutritional-supplements","DOI":"10.1016\/B978-0-12-812491-8.00010-2"},{"key":"5006_CR126","doi-asserted-by":"publisher","first-page":"515","DOI":"10.5603\/CJ.2016.0074","volume":"23","author":"M Mogielnicki","year":"2016","unstructured":"Mogielnicki M et al (2016) The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept. Cardiol J 23:515\u2013517","journal-title":"Cardiol J"},{"key":"5006_CR127","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/nu14030477","volume":"14","author":"R Mollace","year":"2022","unstructured":"Mollace R et al (2022) Comparative effect of bergamot polyphenolic fraction and red yeast rice extract in rats fed a hyperlipidemic diet: Role of antioxidant properties and PCSK9 expression. Nutrients 14:477","journal-title":"Nutrients"},{"key":"5006_CR128","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2017.03.023","volume":"120","author":"AA Momtazi","year":"2017","unstructured":"Momtazi AA, Banach M, Pirro M, Katsiki N, Sahebkar A (2017) Regulation of PCSK9 by nutraceuticals. Pharmacol Res 120:157\u2013169","journal-title":"Pharmacol Res"},{"key":"5006_CR129","doi-asserted-by":"publisher","first-page":"149719","DOI":"10.1016\/j.scitotenv.2021.149719","volume":"801","author":"MF Montenegro-Land\u00edvar","year":"2021","unstructured":"Montenegro-Land\u00edvar MF et al (2021) Polyphenols and their potential role to fight viral diseases: An overview. Sci Total Environ 801:149719","journal-title":"Sci Total Environ"},{"key":"5006_CR130","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12931-025-03178-w","volume":"26","author":"T Morelli","year":"2025","unstructured":"Morelli T, Freeman A, Staples KJ, Wilkinson TMA (2025) Hidden in plain sight: the impact of human rhinovirus infection in adults. Respir Res 26:120. https:\/\/doi.org\/10.1186\/s12931-025-03178-w","journal-title":"Respir Res"},{"key":"5006_CR131","doi-asserted-by":"publisher","unstructured":"Morofuji Y et al (2022) Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharmaceuticals (Basel) 15. https:\/\/doi.org\/10.3390\/ph15020151","DOI":"10.3390\/ph15020151"},{"key":"5006_CR132","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2017.03.014","volume":"142","author":"BC Mounce","year":"2017","unstructured":"Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M (2017) Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Res 142:148\u2013157","journal-title":"Antiviral Res"},{"key":"5006_CR133","doi-asserted-by":"publisher","first-page":"101279","DOI":"10.1016\/j.mam.2024.101279","volume":"97","author":"K Muzammil","year":"2024","unstructured":"Muzammil K et al (2024a) NRF2-mediated regulation of lipid pathways in viral infection. Mol Aspects Med 97:101279","journal-title":"Mol Aspects Med"},{"key":"5006_CR134","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12934-024-02355-8","volume":"23","author":"K Muzammil","year":"2024","unstructured":"Muzammil K et al (2024b) Potential use of proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibition and prevention method in viral infection. Microb Cell Fact 23:90","journal-title":"Microb Cell Fact"},{"key":"5006_CR135","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jacc.2022.10.030","volume":"81","author":"EP Navarese","year":"2023","unstructured":"Navarese EP et al (2023) PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection. J Am Coll Cardiol 81:224\u2013234","journal-title":"J Am Coll Cardiol"},{"key":"5006_CR136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00203-025-04632-5","volume":"208","author":"MS Nawrooz","year":"2025","unstructured":"Nawrooz MS, Taher WM, Alwan M, Jawad M, Mushtaq H, Allela OQB (2025) The role of low-density lipoprotein receptors in emerging and reemerging viruses: a review with examples from human metapneumovirus and beyond. Arch Microbiol 208:79. https:\/\/doi.org\/10.1007\/s00203-025-04632-5","journal-title":"Arch Microbiol"},{"key":"5006_CR137","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00203-025-04632-5","volume":"208","author":"MS Nawrooz","year":"2026","unstructured":"Nawrooz MS, Taher WM, Alwan M, Jawad M, Mushtaq H, Allela OQB (2026) The role of low-density lipoprotein receptors in emerging and reemerging viruses: a review with examples from human metapneumovirus and beyond. Arch Microbiol 208:79","journal-title":"Arch Microbiol"},{"key":"5006_CR138","doi-asserted-by":"publisher","unstructured":"Nowacka A, \u015aniegocki M, Zi\u00f3\u0142kowska EA (2025) PCSK9 Regulation of Lipid Metabolism in the Nervous System: Implications for Schwann Cell Function and Peripheral Neuropathy. Cells 14. https:\/\/doi.org\/10.3390\/cells14181479","DOI":"10.3390\/cells14181479"},{"key":"5006_CR139","first-page":"61","volume":"18","author":"CC Ochin","year":"2018","unstructured":"Ochin CC, Garelnabi M (2018) Berberine encapsulated PLGA-PEG nanoparticles modulate PCSK-9 in HepG2 cells. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular &. Hematol Disorders) 18:61\u201370","journal-title":"Hematol Disorders)"},{"key":"5006_CR140","doi-asserted-by":"publisher","first-page":"265","DOI":"10.22038\/ajp.2022.21539","volume":"13","author":"S Omidvar Tehrani","year":"2023","unstructured":"Omidvar Tehrani S, Ghasemzadeh Rahbardar M, Shoorgashti K, Dehghan Nayeri MJ, Mohammadpour AH, Hosseinzadeh H (2023) Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial. Avicenna J Phytomed 13:265\u2013279. https:\/\/doi.org\/10.22038\/ajp.2022.21539","journal-title":"Avicenna J Phytomed"},{"key":"5006_CR141","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/plants11141835","volume":"11","author":"T Ongtanasup","year":"2022","unstructured":"Ongtanasup T et al (2022) The cholesterol-modulating effect of the new herbal medicinal recipe from yellow vine (Coscinium fenestratum (Goetgh.)), ginger (Zingiber officinale Roscoe.), and safflower (Carthamus tinctorius L.) on suppressing PCSK9 expression to upregulate LDLR expression in HepG2 cells. Plants 11:1835","journal-title":"Plants"},{"key":"5006_CR142","doi-asserted-by":"publisher","first-page":"570355","DOI":"10.3389\/fgene.2020.570355","volume":"11","author":"D Oommen","year":"2020","unstructured":"Oommen D, Kizhakkedath P, Jawabri AA, Varghese DS, Ali BR (2020) Proteostasis Regulation in the Endoplasmic Reticulum: An Emerging Theme in the Molecular Pathology and Therapeutic Management of Familial Hypercholesterolemia. Front Genet 11:570355. https:\/\/doi.org\/10.3389\/fgene.2020.570355","journal-title":"Front Genet"},{"key":"5006_CR143","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1631\/jzus.B1300307","volume":"15","author":"J-y Pang","year":"2014","unstructured":"Pang J-y, Zhao K-j, Wang J-b, Ma Z-j, Xiao X-h (2014) Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. J Zhejiang University-SCIENCE B 15:533\u2013539","journal-title":"J Zhejiang University-SCIENCE B"},{"key":"5006_CR145","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2013.08.090","volume":"440","author":"S Park","year":"2013","unstructured":"Park S et al (2013) Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses. Biochem Biophys Res Commun 440:14\u201319","journal-title":"Biochem Biophys Res Commun"},{"key":"5006_CR144","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/14756366.2016.1265519","volume":"32","author":"J-Y Park","year":"2017","unstructured":"Park J-Y et al (2017) Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem 32:504\u2013512","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5006_CR146","doi-asserted-by":"publisher","first-page":"669362","DOI":"10.3389\/fphar.2021.669362","volume":"12","author":"KS Pawar","year":"2021","unstructured":"Pawar KS et al (2021) Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: A randomized clinical trial. Front Pharmacol 12:669362","journal-title":"Front Pharmacol"},{"key":"5006_CR147","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/jcmm.13273","volume":"21","author":"M Pirro","year":"2017","unstructured":"Pirro M et al (2017) Hepatitis C virus and proprotein convertase subtilisin\/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism. J Cell Mol Med 21:3150\u20133161","journal-title":"J Cell Mol Med"},{"key":"5006_CR148","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2018.11.026","volume":"280","author":"M Pirro","year":"2019","unstructured":"Pirro M et al (2019) NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY (HIV) randomized cross-over trial. Atherosclerosis 280:51\u201357","journal-title":"Atherosclerosis"},{"key":"5006_CR149","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.fitote.2012.04.012","volume":"83","author":"D Potdar","year":"2012","unstructured":"Potdar D, Hirwani R, Dhulap S (2012) Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia 83:817\u2013830","journal-title":"Fitoterapia"},{"key":"5006_CR150","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1128\/AAC.00307-16","volume":"60","author":"X Qiu","year":"2016","unstructured":"Qiu X et al (2016) Prophylactic efficacy of quercetin 3-\u03b2-O-D-glucoside against Ebola virus infection. Antimicrob Agents Chemother 60:5182\u20135188","journal-title":"Antimicrob Agents Chemother"},{"key":"5006_CR151","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3389\/fphar.2018.01170","volume":"9","author":"L Qu","year":"2018","unstructured":"Qu L, Li D, Gao X, Li Y, Wu J, Zou W (2018) Di\u2019ao Xinxuekang capsule, a Chinese medicinal product, decreases serum lipids levels in high-fat diet-fed apoe\u2013\/\u2013mice by downregulating PCSK9. Front Pharmacol 9:1170","journal-title":"Front Pharmacol"},{"key":"5006_CR152","doi-asserted-by":"publisher","unstructured":"Rahman MM et al (2021) Multifunctional Therapeutic Potential of Phytocomplexes and Natural Extracts for Antimicrobial Properties. Antibiot (Basel) 10. https:\/\/doi.org\/10.3390\/antibiotics10091076","DOI":"10.3390\/antibiotics10091076"},{"key":"5006_CR153","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.3390\/molecules26185501","volume":"26","author":"T Ratanakomol","year":"2021","unstructured":"Ratanakomol T, Roytrakul S, Wikan N, Smith DR (2021) Berberine inhibits dengue virus through dual mechanisms. Molecules 26:5501","journal-title":"Molecules"},{"key":"5006_CR154","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.febslet.2010.04.067","volume":"584","author":"MM Rechtman","year":"2010","unstructured":"Rechtman MM et al (2010) Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1\u03b1. FEBS Lett 584:2485\u20132490","journal-title":"FEBS Lett"},{"key":"5006_CR155","doi-asserted-by":"publisher","first-page":"31777","DOI":"10.1038\/srep31777","volume":"6","author":"\u00c1 Rojas","year":"2016","unstructured":"Rojas \u00c1 et al (2016) Effect of quercetin on hepatitis C virus life cycle: from viral to host targets. Sci Rep 6:31777","journal-title":"Sci Rep"},{"key":"5006_CR156","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","volume":"389","author":"C Rothwell","year":"2009","unstructured":"Rothwell C et al (2009) Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389:8\u201319","journal-title":"Virology"},{"key":"5006_CR157","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/09564624231196600","volume":"34","author":"VV Ruiz-Herrera","year":"2023","unstructured":"Ruiz-Herrera VV et al (2023) Pilot study on the efficacy and safety of berberine in people with metabolic syndrome and human immunodeficiency virus infection. Int J STD AIDS 34:1042\u20131052","journal-title":"Int J STD AIDS"},{"key":"5006_CR158","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1021\/jf2007248","volume":"59","author":"YB Ryu","year":"2011","unstructured":"Ryu YB et al (2011) Influenza virus neuraminidase inhibitory activity of phlorotannins from the edible brown alga Ecklonia cava. J Agric Food Chem 59:6467\u20136473","journal-title":"J Agric Food Chem"},{"key":"5006_CR159","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-018-0107-8","volume":"16","author":"MS Sabatine","year":"2019","unstructured":"Sabatine MS (2019) PCSK9 inhibitors: clinical evidence and implementation. Nat reviews Cardiol 16:155\u2013165","journal-title":"Nat reviews Cardiol"},{"key":"5006_CR160","doi-asserted-by":"crossref","unstructured":"Sagar R, Pandey SP, Sah AK (2022) Nanotherapeutics of phytoantioxidants for viral infections. Phytoantioxidants Nanotherapeutics :317\u2013350 https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9781119811794","DOI":"10.1002\/9781119811794.ch15"},{"key":"5006_CR161","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/biom14050603","volume":"14","author":"B Salgado","year":"2024","unstructured":"Salgado B et al (2024) Cholesterol Modulation Attenuates the AD-like Phenotype Induced by Herpes Simplex Virus Type 1 Infection. Biomolecules 14:603","journal-title":"Biomolecules"},{"key":"5006_CR162","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.jlr.2021.100130","volume":"62","author":"NG Seidah","year":"2021","unstructured":"Seidah NG (2021) The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer. J Lipid Res 62:100130. https:\/\/doi.org\/10.1016\/j.jlr.2021.100130","journal-title":"J Lipid Res"},{"key":"5006_CR163","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","volume":"43","author":"NG Seidah","year":"2022","unstructured":"Seidah NG, Prat A (2022a) The multifaceted biology of PCSK9. Endocr Rev 43:558\u2013582","journal-title":"Endocr Rev"},{"key":"5006_CR164","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","volume":"43","author":"NG Seidah","year":"2022","unstructured":"Seidah NG, Prat A (2022b) The Multifaceted Biology of PCSK9. Endocr Rev 43:558\u2013582. https:\/\/doi.org\/10.1210\/endrev\/bnab035","journal-title":"Endocr Rev"},{"key":"5006_CR165","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/JS9.0000000000000010","volume":"109","author":"S Sekaran","year":"2023","unstructured":"Sekaran S, Sekar SKR (2023) Repurposing cholesterol lowering drugs in the treatment and management of monkeypox. Int J Surg 109:60\u201361","journal-title":"Int J Surg"},{"key":"5006_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-020-01088-2","volume":"10","author":"J Shao","year":"2020","unstructured":"Shao J, Zeng D, Tian S, Liu G, Fu J (2020) Identification of the natural product berberine as an antiviral drug. AMB Express 10:1\u201311","journal-title":"AMB Express"},{"key":"5006_CR167","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.3390\/cancers12082141","volume":"12","author":"CK Singh","year":"2020","unstructured":"Singh CK et al (2020) Quercetin\u2013resveratrol combination for prostate cancer management in TRAMP mice. Cancers 12:2141","journal-title":"Cancers"},{"key":"5006_CR168","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11886-020-01427-6","volume":"22","author":"D Sinning","year":"2020","unstructured":"Sinning D, Landmesser U (2020) Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran). Curr Cardiol Rep 22:176. https:\/\/doi.org\/10.1007\/s11886-020-01427-6","journal-title":"Curr Cardiol Rep"},{"key":"5006_CR169","doi-asserted-by":"publisher","first-page":"24823","DOI":"10.1038\/s41598-025-08878-3","volume":"15","author":"MK Soliman","year":"2025","unstructured":"Soliman MK, Salem SS (2025) Comparative evaluation of antimicrobial, antibiofilm, antioxidant, antiviral, and antidiabetic activities of copper oxide nanoparticles biofabricated via Opuntia ficus indica. Sci Rep 15:24823","journal-title":"Sci Rep"},{"key":"5006_CR170","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/jmf.2012.2290","volume":"16","author":"JH Song","year":"2013","unstructured":"Song JH, Park KS, Kwon DH, Choi HJ (2013) Anti\u2013human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa. J Med Food 16:274\u2013279","journal-title":"J Med Food"},{"key":"5006_CR171","first-page":"1","volume":"29","author":"PP Sordillo","year":"2015","unstructured":"Sordillo PP, Helson L (2015) Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections. vivo 29:1\u20134","journal-title":"vivo"},{"key":"5006_CR172","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/ijms18071498","volume":"18","author":"V Spigoni","year":"2017","unstructured":"Spigoni V et al (2017) Effects of a new nutraceutical formulation (berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: results from a randomized, double blind, placebo-controlled study. Int J Mol Sci 18:1498","journal-title":"Int J Mol Sci"},{"key":"5006_CR173","doi-asserted-by":"publisher","first-page":"723233","DOI":"10.3389\/fphar.2021.723233","volume":"12","author":"D Stan","year":"2021","unstructured":"Stan D et al (2021a) Natural compounds with antimicrobial and antiviral effect and nanocarriers used for their transportation. Front Pharmacol 12:723233","journal-title":"Front Pharmacol"},{"key":"5006_CR174","doi-asserted-by":"publisher","first-page":"723233","DOI":"10.3389\/fphar.2021.723233","volume":"12","author":"D Stan","year":"2021","unstructured":"Stan D et al (2021b) Natural Compounds With Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation. Front Pharmacol 12:723233. https:\/\/doi.org\/10.3389\/fphar.2021.723233","journal-title":"Front Pharmacol"},{"key":"5006_CR175","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/v13061014","volume":"13","author":"M \u0160udomov\u00e1","year":"2021","unstructured":"\u0160udomov\u00e1 M, Berchov\u00e1-B\u00edmov\u00e1 K, Marzocco S, Liskova A, Kubatka P, Hassan ST (2021) Berberine in human oncogenic herpesvirus infections and their linked cancers. Viruses 13:1014","journal-title":"Viruses"},{"key":"5006_CR176","doi-asserted-by":"publisher","first-page":"140946","DOI":"10.1016\/j.molstruc.2024.140946","volume":"1325","author":"A Susil","year":"2025","unstructured":"Susil A et al (2025) Extraction, isolation, structural analysis, PPAR-\u03b3 binding studies & transactivation, glucose uptake, lipid lowering activity and in silico studies of Pterocarposide, Sabioside and Pterostilbene. J Mol Struct 1325:140946. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140946","journal-title":"J Mol Struct"},{"key":"5006_CR177","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/molecules27072256","volume":"27","author":"S Sut","year":"2022","unstructured":"Sut S et al (2022) NMR, LC-MS Characterization of Rydingia michauxii Extracts, Identification of Natural Products Acting as Modulators of LDLR and PCSK9. Molecules 27:2256","journal-title":"Molecules"},{"key":"5006_CR178","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/mnfr.201400366","volume":"58","author":"MH Tai","year":"2014","unstructured":"Tai MH, Chen PK, Chen PY, Wu MJ, Ho CT, Yen JH (2014) Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells. Mol Nutr Food Res 58:2133\u20132145","journal-title":"Mol Nutr Food Res"},{"key":"5006_CR179","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1002\/ptr.7198","volume":"35","author":"M Tan","year":"2021","unstructured":"Tan M, Ye J, Zhao M, Ke X, Huang K, Liu H (2021) Recent developments in the regulation of cholesterol transport by natural molecules. Phytother Res 35:5623\u20135633","journal-title":"Phytother Res"},{"key":"5006_CR180","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1038\/s41598-019-46891-5","volume":"9","author":"C-F Teng","year":"2019","unstructured":"Teng C-F et al (2019) Chemopreventive effect of phytosomal curcumin on hepatitis B virus-related hepatocellular carcinoma in a transgenic mouse model. Sci Rep 9:10338","journal-title":"Sci Rep"},{"key":"5006_CR181","doi-asserted-by":"publisher","first-page":"19125","DOI":"10.1038\/s41598-021-98243-x","volume":"11","author":"P Thongsri","year":"2021","unstructured":"Thongsri P, Pewkliang Y, Borwornpinyo S, Wongkajornsilp A, Hongeng S, Sa-Ngiamsuntorn K (2021) Curcumin inhibited hepatitis B viral entry through NTCP binding. Sci Rep 11:19125","journal-title":"Sci Rep"},{"key":"5006_CR182","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40119-020-00191-6","volume":"9","author":"S Toth","year":"2020","unstructured":"Toth S, Pella D, Fedacko J (2020) Vaccines targeting PSCK9 for the treatment of hyperlipidemia. Cardiol Therapy 9:323\u2013332","journal-title":"Cardiol Therapy"},{"key":"5006_CR183","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1128\/JVI.01382-16","volume":"90","author":"FS Varghese","year":"2016","unstructured":"Varghese FS et al (2016) The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling. J Virol 90:9743\u20139757","journal-title":"J Virol"},{"key":"5006_CR184","doi-asserted-by":"crossref","unstructured":"Vega RB et al (2025) Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients. Circulation","DOI":"10.1016\/j.atherosclerosis.2024.118514"},{"key":"5006_CR185","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00705-020-04706-3","volume":"165","author":"A Warowicka","year":"2020","unstructured":"Warowicka A, Nawrot R, Go\u017adzicka-J\u00f3zefiak A (2020) Antiviral activity of berberine. Arch Virol 165:1935\u20131945","journal-title":"Arch Virol"},{"key":"5006_CR186","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cid\/civ949","volume":"62","author":"J Whitehorn","year":"2016","unstructured":"Whitehorn J et al (2016) Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 62:468\u2013476","journal-title":"Clin Infect Dis"},{"key":"5006_CR187","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/v8010006","volume":"8","author":"W Wu","year":"2015","unstructured":"Wu W et al (2015) Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses 8:6","journal-title":"Viruses"},{"key":"5006_CR188","doi-asserted-by":"publisher","first-page":"2477647","DOI":"10.1080\/22221751.2025.2477647","volume":"14","author":"Y Xie","year":"2025","unstructured":"Xie Y, Jiao L, Sun Q (2025) Dengue virus and lipid metabolism: unravelling the interplay for future therapeutic approaches. Emerg Microbes Infections 14:2477647. https:\/\/doi.org\/10.1080\/22221751.2025.2477647","journal-title":"Emerg Microbes Infections"},{"key":"5006_CR190","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejmech.2018.11.011","volume":"162","author":"S Xu","year":"2019","unstructured":"Xu S, Luo S, Zhu Z, Xu J (2019) Small molecules as inhibitors of PCSK9: Current status and future challenges. Eur J Med Chem 162:212\u2013233","journal-title":"Eur J Med Chem"},{"key":"5006_CR189","doi-asserted-by":"publisher","first-page":"114106","DOI":"10.1016\/j.biopha.2022.114106","volume":"158","author":"Q Xu","year":"2023","unstructured":"Xu Q et al (2023) PCSK9: A emerging participant in heart failure. Biomed Pharmacother 158:114106","journal-title":"Biomed Pharmacother"},{"key":"5006_CR191","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1002\/ptr.6196","volume":"32","author":"YQ Yan","year":"2018","unstructured":"Yan YQ et al (2018) Anti-influenza activity of berberine improves prognosis by reducing viral replication in mice. Phytother Res 32:2560\u20132567","journal-title":"Phytother Res"},{"key":"5006_CR192","doi-asserted-by":"publisher","unstructured":"Yao Q, Gong J, Lu H, Liu W, Ding L (2025) Advances in molecular regulation and function of LDLR family in viral infection. Front Microbiol Volume 16\u20132025. https:\/\/doi.org\/10.3389\/fmicb.2025.1702637","DOI":"10.3389\/fmicb.2025.1702637"},{"key":"5006_CR193","doi-asserted-by":"publisher","first-page":"659419","DOI":"10.3389\/fimmu.2021.659419","volume":"12","author":"S Yuan","year":"2021","unstructured":"Yuan S, Jiang S-C, Zhang Z-W, Fu Y-F, Hu J, Li Z-L (2021) Quantification of cytokine storms during virus infections. Front Immunol 12:659419","journal-title":"Front Immunol"},{"key":"5006_CR196","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bcp.2007.06.020","volume":"74","author":"Y Zhang","year":"2007","unstructured":"Zhang Y et al (2007) Identification of two herbal compounds with potential cholesterol-lowering activity. Biochem Pharmacol 74:940\u2013947","journal-title":"Biochem Pharmacol"},{"key":"5006_CR197","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fmicb.2019.00286","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang Z et al (2019) Host lipids in positive-strand RNA virus genome replication. Front Microbiol 10:286","journal-title":"Front Microbiol"},{"key":"5006_CR194","doi-asserted-by":"publisher","first-page":"175195","DOI":"10.1016\/j.ejphar.2022.175195","volume":"931","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022) Curcumin nicotinate decreases serum LDL cholesterol through LDL receptor-mediated mechanism. Eur J Pharmacol 931:175195","journal-title":"Eur J Pharmacol"},{"key":"5006_CR195","doi-asserted-by":"publisher","first-page":"1260921","DOI":"10.3389\/fphar.2023.1260921","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Inclisiran: a new generation of lipid-lowering siRNA therapeutic. Front Pharmacol 14:1260921","journal-title":"Front Pharmacol"},{"key":"5006_CR198","doi-asserted-by":"publisher","first-page":"123620","DOI":"10.1016\/j.carbpol.2025.123620","volume":"361","author":"Y Zhao","year":"2025","unstructured":"Zhao Y et al (2025) Structural characterization, evaluation of lipid-lowering activity, and the structure-activity relationship of a pectic polysaccharide from the whole herb of Euphorbia humifusa. Carbohydr Polym 361:123620. https:\/\/doi.org\/10.1016\/j.carbpol.2025.123620","journal-title":"Carbohydr Polym"},{"key":"5006_CR199","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/s40001-025-02937-1","volume":"30","author":"X Zheng","year":"2025","unstructured":"Zheng X et al (2025) Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach. Eur J Med Res 30:690. https:\/\/doi.org\/10.1186\/s40001-025-02937-1","journal-title":"Eur J Med Res"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05006-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:03:42Z","timestamp":1787911422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-05006-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":199,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5006"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05006-1","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"453"}}